Psychological, behavioral, and immune changes after a psychological intervention: A clinical trial

Journal of Clinical Oncology

Volumn 22, Issue 17, 2004, Pages 3570-3580

  Andersen, Barbara L ^a   Farrar, William B ^a   Golden Kreutz, Deanna M ^a   Glaser, Ronald ^a   Emery, Charles F ^a   Crespin, Timothy R ^a   Shapiro, Charles L ^a   Carson III, William E ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CONCANAVALIN A; PHYTOHEMAGGLUTININ;

ANXIETY; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; EMOTIONAL STRESS; FEMALE; HEALTH BEHAVIOR; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; INTERVIEW; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SMOKING; SOCIAL SUPPORT; ADAPTIVE BEHAVIOR; ADULT; AFFECT; AGED; BREAST TUMOR; CELLULAR IMMUNITY; IMMUNOLOGY; MENTAL STRESS; MIDDLE AGED; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SOCIAL ADAPTATION;

ADAPTATION, PSYCHOLOGICAL; ADULT; AFFECT; AGED; BREAST NEOPLASMS; FEMALE; HEALTH BEHAVIOR; HUMANS; IMMUNITY, CELLULAR; MIDDLE AGED; QUALITY OF LIFE; SOCIAL ADJUSTMENT; STRESS, PSYCHOLOGICAL;

EID: 4444257698     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.06.030     Document Type: Article

References (88)

1. Andersen BL: Psychological interventions for cancer patients to enhance the quality of life. J Consult Clin Psychol 60:552-568, 1992
2. Andersen BL: Biobehavioral outcomes following psychological interventions for cancer patients. J Consult Clin Psychol 70:590-610, 2002
3. Helgeson VS, Cohen S, Schulz R, et al: Group Support interventions for women with breast cancer: Who benefits from what? Health Psychol 19:107-114, 2000
4. Goodwin PJ, Leszcz M, Ennis M, et al: The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 345:1719-1726, 2001
5. Spiegel D, Bloom JR, Kraemer HC, et al: Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 2:888-891, 1989
6. Fawzy FI, Fawzy NW, Hyun CS, et al: Malignant melanoma: Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 50:681-689, 1993
7. Richardson JL, Zarnegar Z, Bisno B, et al: Psychosocial status at initiation of cancer treatment and survival. J Psychosom Res 34:189-201, 1990
8. Kuchler T, Henne-Bruns D, Rappat S, et al: Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: Survival results of a trial. Hepatogastroenterology 46:322-335, 1999
9. Cunningham AJ, Edmonds CV, Jenkins GP, et al: A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology 7:508-517, 1998
10. Linn MW, Linn BS, Harris R: Effects of-counseling for late stage cancer patients. Cancer 49:1048-1055, 1982
11. Edelman S, Lemon J, Bell DR, et al: Effects of group CBT on the survival time of patients with metastatic breast cancer. Psychooncology 8:474-481, 1999
12. Berkman LF, Leo-Summers L, Horwitz RI: Emotional support and survival after myocardial infarction: A prospective, population-based study of the elderly. Ann Intern Med 117:1003-1009, 1992
13. Hazuda HP: A critical evaluation of U.S., epidemiological evidence and ethnic variation, in Shumaker SA (ed): Social Support and Cardiovascular Disease. New York, NY, Plenum, 1994, pp 119-142
14. Orth-Gomer K, Rosengren A, Wilhelmsen L: Lack of social support and incidence of coronary heart disease in middle-aged Swedish men. Psychosom Med 55:37-43, 1993
15. Kiecolt-Glaser JK, McGuire L, Robles TF, et al: Psychoneuroimmunology: Psychological influences on immune function and health. J Consult Clin Psychol 70:537-547, 2002
16. Andersen BL, Kiecolt-Glaser JK, Glaser R: A biobehavioral model of cancer stress and disease course. Am Psychol 49:389-404, 1994
17. Keefe FJ, Buffington ALH, Studts JL, et al: Behavioral medicine: 2002 and beyond. J Consult Clin Psychol 70:852-856, 2002
18. Antoni MH, Lehman JM, Klibourn KM, et al: Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol 20:20-32, 2001
19. Horowitz M, Wilner N, Alvarez W: Impact of Events Scale: A measure of subjective stress. Psychosom Med 41:209-218, 1979
20. McNair DM, Lorr M, Droppleman LF: EITS Manual of the Profile of Mood States. San Diego, CA, Educational and Industrial Testing Services, 1971
21. Berkman LF, Syme SL: Social networks, host resistance, and mortality: A nine year follow-up study of Alameda County residents. Am J Epidemiol 109:186-204, 1979
22. Berkman LF: Social networks, host resistance, and mortality: A follow-up study of Alameda County residents. Berkeley, CA, University of California Berkeley, 1977 (dissertation)
23. Procidano ME, Heller K: Measures of perceived social support from friends and from family: Three validation studies. Am J Community Psychol 11:1-24, 1983
24. Spanier GB: Measuring dyadic adjustment: New scales for assessing the quality of marriage and similar dyads. J Marriage Fam 38:15-28, 1976
25. Kristal AR, Shattuck AL, Henry HJ, et al: Rapid assessment of dietary intake of fat, fiber, and saturated fat: Validity of an instrument suitable for community intervention research and nutritional surveillance. Am J Health Promot 4:288-295, 1990
26. Blair SN, Haskell WL, Ho P, et al: Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments. Am J Epidemiol 122:794-804, 1985
27. Hryniuk WM: The importance of dose intensity in the outcome of chemotherapy, in DiVita VT (ed): Important Advances in Oncology. Philadelphia, PA, JB Lippencott, 1988, pp 121-142
28. Hryniuk WM, Levine MN: Analysis of dose intensity of adjuvant chemotherapy trials in stage 11 breast cancer. J Clin Oncol 4:1162-1170, 1986
29. Karnofsky DA, Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer, in Macleod CM (ed): Evaluation of Chemotherapeutic Agents. New York, NY, Columbia University Press, 1949, pp 199-205
30. Mor V, Laliberte L, Morris JN, et al: The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer 53:2002-2007, 1984
31. Yates JW, Chalmer B, McKegney FP: Evaluation of patients with advanced cancer using the Karnofsky Performance Status. Cancer 45:2220-2224, 1980
32. Andersen BL, Farrar WB, Golden-Kreutz D, et al: Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst 90:30-36, 1998
33. White SJ, Freedman LS: Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer 37:849-857, 1978
34. Girden ER: ANOVA Repeated Measures. Sage University Paper Series on Quantitative Applications in the Social Sciences, 07-084. Newbury Park, CA, Sage, 1992, pp 1-76
35. Ohio Department of Health: Community health assessments and the center for public health data and statistics, Ohio Department of Health, Columbus, OH, 2002
36. Surveillance, Epidemiology, and End Results Program (SEER): Division of Cancer Control and Population Sciences. Bethesda, MD, National Cancer Institute, 2000
37. Conover WJ: Practical Nonparametric Statistics (ed 2). New York, NY, John Wiley & Sons, 1980, p 239
38. Sheard T, Maguire P: The effect of psychological interventions on anxiety and depression in cancer patients: Results of two meta-analyses. Br J Cancer 80:1770-1780, 1999
39. v'ant Spijker A, Trijsburg RW, Duivenvoorden HJ: Psychological sequelae of cancer diagnosis: A meta-analytical review of 58 studies after 1980. Psychosom Med 59:280-293, 1997
40. Stark DP, House A: Anxiety in cancer patients. Br J Cancer 83:1261-1267, 2000
41. Weisman AD, Worden JW: The existential plight in cancer: Significance of the first 100 days. Int J Psychiatry Med 7:1-15, 1976
42. Melendez JC, McCrank E: Anxiety-related reactions associated with magnetic resonance imaging examinations. JAMA 270:745-747, 1993
43. Thomas C, Madden F, Jehu D: Psychological effects of stomas-I. Psychosocial morbidity one year after surgery. J Psychosom Res 31:311-316, 1987
44. Andersen BL, Karlsson JA, Anderson B, et al: Anxiety and cancer treatment: Response to stressful radiotherapy. Health Psychol 3:535-551, 1984
45. Morrow GR, Roscoe JA, Hickok JT, et al: Nausea and emesis: Evidence for a biobehavioral perspective. Support Care Cancer 10:96-105, 2002
46. Jacobsen PB, Widows MR, Hann DM, et al: Posttraumatic stress disorder symptoms after bone marrow transplantation for breast cancer. Psychosom Med 60:366-371, 1998
47. Rabin C, Ward S, Leventhal H, et al: Explaining retrospective reports of symptoms in patients undergoing chemotherapy: Anxiety, initial symptom experience, and post treatment symptoms. Health Psychol 20:91-98, 2001
48. Redd WH, Montgomery GH, DuHamel KN: Behavioral intervention for cancer-treatment side-effects. J Natl Cancer Inst 93:810-823, 2001
49. Winningham ML, Nail LM, Burke MB, et al: Fatigue and the cancer experience: The state of the knowledge. Oncol Nurs Forum 21:23-36, 1994
50. Vogelzang NJ, Breitbart W, Cella D, et al: Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 34:4-12, 1997
51. Capone MA, Good RS, Westie KS, et al: Psychosocial rehabilitation of gynecologic oncology patients. Arch Phys Med Rehabil 61:128-132, 1980
52. Spiegel D, Bloom JR, Yalom I: Group support for patients with metastatic cancer: A randomized outcome study. Arch Gen Psychiatry 38:527-533, 1981
53. Cain EN, Kohorn EI, Quinlan DM, et al: Psychosocial benefits of a cancer support group. Cancer 57:183-189, 1986
54. Houts PS, Whitney CW, Mortel R, et al: Former cancer patients as counselors of newly diagnosed cancer patients. J Natl Cancer Inst 76:793-796, 1986
55. Maguire P, Brooke M, Tait A, et al: The effect of counseling on physical disability and social recovery after mastectomy. Clin Oncol 9:319-324. 1983
56. Reifman A: Social relationships, recovery from illness, and survival: A literature review. Ann Behav Med 17:124-131, 1995
57. Michael W, Berkman LF, Colditz GA, et al: Social networks and health-related quality of life in breast cancer survivors: A prospective study. J Psychosom Res 52:285-293, 2002
58. Cohen S, Hoberman HM: Positive events and social supports as buffers of life change stress. J Appl Soc Psychol 13:99-125, 1983
59. Wethington E, Kessler RC: Perceived support, received support, and adjustment to stressful life events. J Health Soc Behav 27:78-89, 1986
60. Helgeson VS, Cohen S: Social support and adjustment to cancer: Reconciling descriptive, correlational, and intervention research. Health Psychol 15:135-148, 1996
61. Nordevang E, Callmer E, Marmur A, et al: Dietary intervention in breast cancer patients: Effects on food choice. Eur J Clin Nutr 46:387-396, 1992
62. Chlebowski RT, Blackburn GL, Buzzard M, et al: Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. J Clin Oncol 11:2072-2080, 1993
63. Pierce JP, Faerber S, Wright FA, et al: Feasibility of a randomized trial of a high-vegetable diet to prevent breast cancer recurrence. Nutr Cancer 28:282-288, 1997
64. Kristal AR, Shattuck AL, Bowen DJ, et al: Feasibility of using volunteer research staff to deliver and evaluate a low-fat dietary intervention: The American Cancer Society Breast Cancer Dietary Intervention Project. Cancer Epidemiol Biomarkers Prev 6:459-467, 1997
65. MacVicar MG, Winningham ML, Nickel JL: Effects of aerobic interval training on cancer patient's functional capacity. Nurs Res 38:348-351, 1989
66. Segal R, Evans W, Johnson D. et al: Structured exercise improves physical functioning in women with stages I and II breast cancer: Results of randomized controlled trial. J Clin Oncol 19:657-665, 2001
67. Gritz ER. Carr CR, Rapkin D, et al: Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 2:261-270, 1993
68. Wewers ME, Bowen JM, Stanislaw AE, et al: A nurse-delivered smoking cessation intervention among hospitalized postoperative patients-Influence of a smoking-related diagnosis: A pilot study. Heart Lung 23:151-156, 1994
69. Fawzy FI, Cousins N, Fawzy NW, et al: A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry 47:720-725, 1990
70. Schnell RA, James BA, Malstrom M, et al: Longitudinal predictors of continued tobacco use among patients diagnosed with cancer. Ann Behav Med 25:214-221, 2003
71. Manley M, Epps RP, Husten C, et al: Clinical interventions in tobacco control: A National Cancer Institute training program for physicians. JAMA 266:3172-3173, 1991
72. Fiore MC, Bailey WC, Cohen SJ, et al: Smoking cessation. Clinical practice guideline no. 18. Rockville, MD, US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research publication 96-0692, 1996
73. Fiore MC, Bailey WC, Cohen SJ, et al: Treating tobacco use and dependence: A clinical practice guideline. Rockville. MD, US Department of Health and Human Services, Public Health Service, Agency for Health Care Quality Research publication 00-0032, 2000
74. Partridge AH, Avorn J, Wang PS, et al: Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 94:652-661, 2002
75. Fawzy FI, Kemeny ME, Fawzy NW, et al: A structured psychiatric intervention for cancer patients. II. Changes over time in immunological measures Arch Gen Psychiatry 47:729-735, 1990
76. Elsesser K, van Berkel M, Sartory G, et al: The effects of anxiety management training on psychological variables and immune parameters in cancer patients: A pilot study. Beh Cogn Psychoth 22:13-23, 1994
77. Larson MR, Duberstein PR, Talbot NL, et al: A presurgical psychosocial intervention for breast cancer patients: Psychological distress and the immune response. J Psychosom Res 48:187-194, 2000
78. Richardson MA, Post-White J, Grimm EA, et al: Coping, life attitudes, and immune responses to imagery and group support after breast cancer treatment. Altern Ther Health Med 3:62-70, 1997
79. Van der Pompe G, Duivenoorden HJ, Antoni MH, et al: Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients: An exploratory study. J Psychosom Res 42:453-466, 1997
80. Hosaka T, Tokuda Y, Sugiyama Y, et al: Effects of a structured psychiatric intervention on immune function of cancer patients. Tokai J Exp Clin Med 25:183-188, 2000
81. Gruber BL, Hersh SP, Hall NRS, et al: Immunological responses of breast cancer patients to behavioral interventions. Biofeedback Self Regul 18:1-22, 1993
82. Kaplan DH, Shankaran V, Digne AS, et al: Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA 95:7556-7561, 1998
83. Edelman S, Bell DR, Kidman AD: A group cognitive behaviour therapy programme with metastatic breast cancer patients. Psychooncology 8:295-305, 1999
84. Spiegel D, Bloom JR: Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med 45:333-339, 1983
85. Richardson JL, Marks G, Johnson CA, et al: Path model of multidimensional compliance with cancer therapy. Health Psychol 6:183-207, 1987
86. Richardson JL, Marks G, Levine A: The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy. J Clin Oncol 6:1746-1752, 1988
87. Edmonds CV, Lockwood GA, Cunningham AJ: Psychological response to long-term group therapy: A randomized trial with metastatic breast cancer patients. Psychooncology 8:74-91, 1999
88. Bordeleau L, Szalai JP, Ennis M, et al: Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: Overall effects of the intervention and an explanation of missing data. J Clin Oncol 21:1944-1951, 2003